Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Intangibles (2019 - 2025)

CorMedix's Intangibles history spans 4 years, with the latest figure at $379.1 million for Q4 2025.

  • For Q4 2025, Intangibles rose 18853.6% year-over-year to $379.1 million; the TTM value through Dec 2025 reached $379.1 million, up 18853.6%, while the annual FY2025 figure was $379.1 million, 18853.6% up from the prior year.
  • Intangibles for Q4 2025 was $379.1 million at CorMedix, up from $1.7 million in the prior quarter.
  • Across five years, Intangibles topped out at $379.1 million in Q4 2025 and bottomed at $1.7 million in Q2 2025.